Corvus Pharmaceuticals stock (CRVS) swings as $150M share sale follows eczema-data surge
New York, Jan 21, 2026, 12:27 EST — Regular session Shares of Corvus Pharmaceuticals edged up 0.3% to $21.48 by 12:11 p.m. EST Wednesday, swinging between $19.05 and a peak of $23.96 during a volatile session sparked by the company’s fresh capital-raising announcement. The moves carry weight since Corvus remains a clinical-stage firm. Following a strong rally on initial eczema…